High Energy Substrates (e.g., Fluorescent, Chemiluminescent, Radioactive, Etc.) Patents (Class 435/968)
-
Patent number: 7303926Abstract: The present invention discloses dye-azide derivatives and their bioconjugates for dual phototherapy of tumors and other lesions. The compounds of the present invention may contain either a mixture of Type 1 and Type 2 agents or a single entity that integrates both units in the same molecules. The compounds are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and nitrene at the lesion of interest.Type: GrantFiled: February 11, 2004Date of Patent: December 4, 2007Assignee: Mallinckrodt, IncInventors: Raghavan Rajagopalan, Samuel I. Achilefu, Joseph E. Bugaj, Richard B. Dorshow
-
Patent number: 7297555Abstract: In accordance with the present invention, it has been discovered that introduction of hydrophilic sulfoalkyl substituents and/or hydrophilic linkers derived from homocysteic acid, cysteic acid, glycine peptides, tetraethylene oxide, and the like, offset the hydrophobicity of the acridinium ring system to produce a more soluble label which can be attached to an antibody at higher loading before precipitation and aggregation problems are encountered. Additional compounds described herein contain linkers derived from short peptides and tetraethylene oxide which increase aqueous solubility due to hydrogen bonding with water molecules. The present invention also embraces reagents for multiple acridinium labeling for signal amplification composed of a peptide bearing several acridinium esters with sulfonate groups at regularly spaced intervals for increased solubility. The invention also embraces assays employing the above-described compounds.Type: GrantFiled: July 14, 2005Date of Patent: November 20, 2007Assignee: Quest Diagnostics Investments IncorporatedInventors: Ramon Evangelista, Martha Garrity
-
Patent number: 7291474Abstract: Disclosed are compounds of the general formulas: wherein Y is a moiety capable of being cleaved by a hydrolytic enzyme; L is a detectable label; X is a linking group; Z is a halogen; and R is hydrogen, an alkyl, or a halogen. Compounds of this general formula can be used as substrates in an analyte-dependent enzyme activation system, such as that employed in connection with catalyzed reporter depositions. Also disclosed are assays using the compounds, and kits for carrying out the assays.Type: GrantFiled: June 10, 2004Date of Patent: November 6, 2007Assignee: PerkinElmer LAS, Inc.Inventor: Mark N. Bobrow
-
Patent number: 7288368Abstract: A membrane receptor reagent and assay is disclosed in which liposomes are bound to an evanescent wave emitting surface. Membrane receptors on the liposome's fluid lipid bilayer membrane are labeled with a fluorescent or luminescent moiety. These membrane receptors are free to diffuse randomly throughout the liposome surface, and thus tend to redistribute according to externally applied forces. The evanescent wave-emitting surface additionally contains reagents that reversibly bind to the membrane receptors, tending to bring them closer to region of high evanescent wave intensity. Test analytes that disrupt or promote the association between the membrane receptors and the surface reagents act to change the average distance between the membrane receptors and the evanescent wave emitting surface, resulting in a change in the fluorescent or luminescent signal.Type: GrantFiled: July 6, 2004Date of Patent: October 30, 2007Inventor: Stephen Eliot Zweig
-
Patent number: 7282373Abstract: A self-assembled relay probe for detecting a target material is provided including: a first peptide tag bound to the target material; and a first fluorescent conjugate including a first fluorochrome and a first tag binding group; wherein the first fluorescent conjugate selectively associates with the first tag. The probe further includes a second peptide tag bound to the target material; and a second fluorescent conjugate including a second fluorochrome having a longer wavelength and distinct excitation and emission maxima from the first fluorochrome and a second tag binding group. Upon exposure to the target material, the first and second fluorescent conjugates independently associate with the first and second peptide tags, respectively, so as to be a distance apart represented by about 0.Type: GrantFiled: October 24, 2005Date of Patent: October 16, 2007Assignee: Rutgers, The State University of New JerseyInventors: Richard H. Ebright, Yon W. Ebright
-
Patent number: 7282339Abstract: The present invention provides ligand-detection reagents, ligand analogs and methods for determining the presence of a ligand in a sample. The ligand-detection reagent comprises a ligand-binding antibody and a ligand analog to form an antibody-ligand analog complex wherein the ligand analog is covalently bonded to a reporter molecule. This complex may additionally comprise a labeling protein non-covalently bonded to the antibody to form a ternary complex wherein the labeling protein comprises a monovalent antibody fragment or a non-antibody protein that is covalently bonded to a label moiety. The reporter molecule is either quenched by the ligand-binding antibody or by the label moiety of the labeling protein, depending on the reporter molecule and the ligand-binding antibody, wherein the amount of quenching is directly related to the amount of ligand present in the sample.Type: GrantFiled: September 17, 2004Date of Patent: October 16, 2007Assignee: Invitrogen CorporationInventors: Joseph Beechem, Kyle Richard Gee, David Carl Hagen, Iain D Johnson, Hee-Chol Kang, Christina Pastula
-
Patent number: 7255998Abstract: A method for detecting a cytokine in a biological fluid sample with a high sensitivity is provided. A time-resolved fluoroimmunoassay (TR-FIA) method including a step of forming on a solid phase a composite in which a cytokine is captured and which includes a fluorescent structural portion which has been complexed with a lanthanoid metal ion, and measuring fluorescence of the fluorescent structural portion. The composite is formed of a structure in which (a) a first antibody including a portion bound to a solid phase and a region bindable to a cytokine; (b) the cytokine; (c) a second antibody including a region bindable to the cytokine and a portion to which biotin is bound; (d) a conjugate including streptoavidin or avidin and a fluorescent structural portion capable of being complexed with a lanthanoid metal ion; and (e) the lanthanoid metal ion are bound. The fluorescent structural portion is represented by General Formula (I): R—Ar—C(?O)—CH2—C(?O)—CnF2n—X.Type: GrantFiled: September 28, 2000Date of Patent: August 14, 2007Assignee: Japan Science and Technology CorporationInventors: Kei Tashiro, Tasuku Honjo, Masaya Ikegawa, Kazuko Matsumoto
-
Patent number: 7247726Abstract: Novel compounds comprising a C—C double bond substituted at one carbon with two sulfur atom-containing groups are disclosed. The compounds are useful in methods and compositions for generating chemiluminescence rapidly by reaction with a peroxidase enzyme and a peroxide. The chemiluminescence thus produced can be used as a detectable signal in assays for peroxidase enzymes or peroxide-producing enzymes and in assays employing enzyme-labeled specific binding pairs.Type: GrantFiled: December 18, 2002Date of Patent: July 24, 2007Assignee: Lumigen, Inc.Inventors: Hashem Akhavan-Tafti, Renuka de Silva, Wenhua Xie
-
Patent number: 7235370Abstract: A method of making a derivatized aminoglycoside includes reacting an aminoglycoside with at least 2 equivalents of a divalent metal ion in an aprotic solvent to complex two neighboring amino group and hydroxyl group pairs; reacting the non-complexed amino groups with a protecting reagent to provide protecting groups; removing the divalent metal ion to provide two unprotected amino groups; reacting one of the unprotected amino groups with a reactive substance containing an linker, a carrier, or a label; and removing the protecting groups. This method can be used to produce novel compounds and reagents.Type: GrantFiled: July 22, 2003Date of Patent: June 26, 2007Assignee: Roche Diagnostics Operations, Inc.Inventors: Mitali Ghoshal, Salvatore J. Salamone
-
Patent number: 7202089Abstract: A method is described for the early detection of stroke which uses a reagent which includes a fluorescently modified fatty acid binding protein. A fluorescence difference is noted between the bound and unbound condition. Elevated levels of unbound free fatty acids from blood are used as indicators of stroke.Type: GrantFiled: September 13, 2002Date of Patent: April 10, 2007Inventor: Alan Kleinfeld
-
Patent number: 7192786Abstract: This invention relates to a biospecific assay method, in which microparticles coated with the bioaffinity reactant A binding the analyte to be assayed; the sample to be analyzed, and the labelled bioaffinity reactant B are mixed. After the binding reaction the signal strength from the labelled bioaffinity reactant B bound to the microparticles is quantitated for the determination of the concentration of the analyte in the sample. According to the invention, such an amount of sample and microparticles is used in the assay that after binding of the analyte of the sample to the said amount of microparticles, each individual microparticle will emit such a signal strength as to allow the measurement of the analyte concentration over the whole range of typical analyte concentrations, and the signal strength from each microparticle is measured separately.Type: GrantFiled: June 7, 1995Date of Patent: March 20, 2007Assignee: Wallac OyInventors: Timo Nils-Erik Lövgren, Antti Juhana Iitiä, Kim Sverker Immanuel Pettersson
-
Patent number: 7169574Abstract: The invention concerns the use of a PyA-(Z)x-pNF group in a substrate for detecting, identifying and/or analyzing by fluorometry peptidases or proteases capable of cleaving the or a bond between a PyA and pNF and/or compounds with inhibiting or activating activity with respect to enzymes capable of cleaving said bond.Type: GrantFiled: April 6, 2001Date of Patent: January 30, 2007Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (C.N.R.S.)Inventors: Bernard Pierre Roques, Nathalie Luciani, Marie-Claude Fournie-Zaluski, Hugues de Rocquigny
-
Patent number: 7118878Abstract: The invention provides kits and methods for increasing the sensitivity of a bio-luminescent assay, which employ an organic compound that, for instance, reduces luminescence that is not dependent on the presence of an analyte by at least about 10 fold and reduces luminescence that is dependent on the presence of an analyte by less than about 7 fold, reduces luminescence generated by luminogenic molecules not bound to an enzyme by at least about 10 fold and reduces the luminescence generated by luminogenic molecules bound to an enzyme by less than about 7 fold, or reduces autoluminescence by at least about 10 fold and reduces luminescence that is dependent on the presence of an analyte by less than about 7 fold.Type: GrantFiled: June 9, 2000Date of Patent: October 10, 2006Assignee: Promega CorporationInventors: Erika Hawkins, John M. Centanni, Jacqueline Sankbeil, Keith V. Wood
-
Patent number: 7109043Abstract: A fluorescent probe for measuring magnesium ion, which can selectively form a complex with magnesium ion in aqueous system is disclosed. The fluorescent probe for measuring magnesium ion according to the present invention has the structure represented by the following Formula [I]: (wherein R1 represents a hydrogen atom, metal atom or an ester-forming group; A represents a group which forms a ring structure together with carbon atom 1 and carbon atom 2; and X is a fluorescent group which may form a condensed ring together with the ring containing the group A).Type: GrantFiled: July 25, 2001Date of Patent: September 19, 2006Assignees: Japan Science and Technology Corporation, The Kanagawa Academy of Science and Technology Foundation, Keio UniversityInventors: Koji Suzuki, Yoshio Suzuki, Kotaro Oka
-
Patent number: 7105310Abstract: Methods and compositions for detecting and characterizing target biomolecules using sensitizer-linked substrate molecules are disclosed.Type: GrantFiled: July 19, 2000Date of Patent: September 12, 2006Assignee: California Institute of TechnologyInventors: Harry B. Gray, Brian R. Crane, Jay R. Winkler, Ivan Julian Dmochowski, Jonathan J. Wilker, Alexander Robert Dunn
-
Patent number: 7101667Abstract: The present invention provides lanthanide binding tags (LBT) that selectively complex trivalent lanthanide (Ln) ions and afford stable complexes with desirable physical properties, including at least one of fluorescence and anomalous x-ray scattering.Type: GrantFiled: September 5, 2002Date of Patent: September 5, 2006Assignees: Massachusetts Institute of Technology, Trustees of Boston UniversityInventors: Barbara Imperiali, Karen N. Allen, Katherine J. Franz
-
Patent number: 7101677Abstract: The present invention relates to receptor/reporter fusion protein based assays for detecting the effect test compounds have on a particular membrane receptor, as well as to receptor/reporter fusion proteins for use in such assays and compounds identified by the assays as having interesting/useful effects. Suitable membrane receptors are growth factor receptors, cytokine receptors, ion channels and integrins including any subtypes, mutants, homologs and chimeric forms of such receptors. The assay may be to study G-protein coupled receptors (GPCRs).Type: GrantFiled: February 18, 2000Date of Patent: September 5, 2006Assignee: University Court of the University of GlasgowInventors: Graeme Milligan, Edward Stephen Rees
-
Patent number: 7091051Abstract: A chemiluminescence method characterized in that when a 1,2-dioxetane derivative of the formula 1: wherein each of R1, R2, R3, R4 and R5 which are independent of one another, is a hydrogen atom, an alkyl group or an aryl group, or each pair of R2 and R3, and R4 and R5, which are independent of each other, may form together a cyclic alkyl group, R6 is a hydroxyl group, an alkoxyl group, an aralkyloxy group, a group represented by —OSi(R8R9R10) (provided that each of R8, R9 and R10 which are independent of one another, is an alkyl group or an aryl group), a phosphate group or a group represented by S(C?O)R11 (provided that R11 is an alkyl group or an aryl group), and R7 is a hydrogen atom, a halogen atom, an alkyl group or an alkoxyl group, is let generate chemiluminescence by means of an activator selected from the group consisting of a base, an acid, a salt, a fluorine compound, an enzyme, a catalyst and an amine compound, a cationic surfactant and a fluorescent material are made to coexist.Type: GrantFiled: August 25, 2004Date of Patent: August 15, 2006Assignee: Tosoh CorporationInventors: Kenji Kitaoka, Masashi Yamada, Seiji Kawaguchi
-
Patent number: 7074554Abstract: Materials and methods are provided to inhibit HIV replication in targeted host cells.Type: GrantFiled: December 10, 2003Date of Patent: July 11, 2006Assignee: The Board of Regents of the University of NebraskaInventors: Tsuneya Ikezu, Gary Leisman, Kimberly A. Carlson, Howard E. Gendelman
-
Patent number: 7052861Abstract: Graphitic nanotubes, which include tubular fullerenes (commonly called “buckytubes”) and fibrils, which are functionalized by chemical substitution, are used as solid supports in electrogenerated chemiluminescence assays. The graphitic nanotubes are chemically modified with functional group biomolecules prior to use in an assay. Association of electrochemiluminescent ruthenium complexes with the functional group biomolecule-modified nanotubes permits detection of molecules including nucleic acids, antigens, enzymes, and enzyme substrates by multiple formats.Type: GrantFiled: December 5, 2001Date of Patent: May 30, 2006Assignee: Meso Scale Technologies, LLC.Inventors: Richard J. Massey, Mark T. Martin, Liwen Dong, Ming Lu, Alan Fischer, Fabian Jameison, Pam Liang, Robert Hoch, Jonathan K. Leland
-
Patent number: 7045311Abstract: The activity of a cell surface protease, particularly an ADAM, is determined in a rapid and sensitive assay employing a whole cell system. The assays are effective to identify effector molecules that affect the activity of a cell surface protease directly or indirectly, and to screen for therapeutic agents that modulate those effector molecules. The assays can also be used to screen for therapeutic agents that modulate the activity of a cell surface protease associated with a disease or medical condition. Kits comprising at least one component of the present assays are also provided.Type: GrantFiled: October 25, 2002Date of Patent: May 16, 2006Assignee: Monogram Biosciences, Inc.Inventors: Gary J. Ciambrone, Ian Gibbons
-
Patent number: 6995023Abstract: The proteins in a biological sample that is sought to be analyzed for its protein composition by an electrophoretic or chromatographic procedure are coupled to a dye in an unusually efficient manner by combining the sample with a solid dry composition containing the dye, a buffering agent, and in preferred embodiments, a denaturing agent as well. The solid and dry form of the composition prevents the dye from deteriorating or decomposing, and the combination of components in the composition allows the dye to couple to the proteins in a relatively uniform manner with no overstaining of the protein when the composition and the sample are heated together and held at an elevated temperature for a short period of time.Type: GrantFiled: October 21, 2002Date of Patent: February 7, 2006Assignee: Bio-Rad Laboratories, Inc.Inventors: Mingde Zhu, Lee Olech
-
Patent number: 6991914Abstract: A silent marker, method of marking a petroleum product with the silent marker, and method of detecting the silent marker. The marker is an ester derivative of fluorescent material, and the silent marker may be detected by measuring the fluorescence generated from the selective hydrolysis of the ester moiety under enzymatic action.Type: GrantFiled: July 12, 2001Date of Patent: January 31, 2006Assignee: SK CorporationInventors: Hwan-Ho Park, Dong-Hyon Sheen, Hyun-Seok Kim, Sung-Ho Park
-
Patent number: 6984498Abstract: A cancer screening method is provided, wherein the method is characterized by administering a compound to a patient, the compound being a complex of a fluorescent marker and a radioactive marker, in a dose emitting between 5 Gy and 20 Gy radiation. Cells are then collected preferably through non-invasive or minimally invasive means. If fluorescence is observed in the exfoliated cells, tomographic scanning is conducted to further locate and/or confirm suspected malignant areas or metastatic areas. Further observation or treatment may be conducted either through fluorescence guided endoscopy, photo-dynamic therapy, and/or radiation treatment.Type: GrantFiled: April 30, 2004Date of Patent: January 10, 2006Inventor: Edwin L. Adair
-
Patent number: 6979553Abstract: Transmembrane potential measurement methods using cationic dyes, and anionic dyes are provided. Compositions of the cationic and anionic dyes and microfluidic systems which include the dyes and membranes are provided in conjunction with processing elements for transmembrane potential measurements.Type: GrantFiled: September 5, 2003Date of Patent: December 27, 2005Assignee: Caliper Life Sciences, Inc.Inventors: Javier Anibal Farinas, H. Garrett Wada
-
Patent number: 6972198Abstract: The invention relates to a method for determining the conformational state of a protein, comprising the steps of: a) providing a first binding partner which is capable of binding to the protein in a manner dependent on the conformational state of the protein and which generates a signal in a manner dependent on the binding of the first binding partner to the protein; and b) contacting the protein with the first binding partner and determining the conformational state of the protein by assessing the labelling of the protein by the binding of the first binding partner.Type: GrantFiled: February 24, 2000Date of Patent: December 6, 2005Assignee: Cyclacel, Ltd.Inventors: Roger K. Craig, John Colyer
-
Patent number: 6955886Abstract: The invention provides a scintillation proximity assay for detecting peptidoglycan synthesis. The assay is especially suitable for high throughput screening of compounds affecting peptidoglycan synthesis.Type: GrantFiled: May 4, 1999Date of Patent: October 18, 2005Assignee: AstraZeneca ABInventors: Sunita Desousa, Dwarakanath Prahlad
-
Patent number: 6951760Abstract: The invention relates to a method for detection of an analyte in a test sample by a specific binding reaction among the analyte, a specific binding partner for the analyte, and an (immuno)reactant provided with a label, characterized in that the label is a lanthanide ion-ligand complex wherein the lanthanide ion is neodymium(III) ion (Nd3+), ytterbium(III) ion (Yb3+), or erbium(III) ion (Er3+) and the ligand comprises or is in contact with a sensitizing moiety which absorbs in the 400-1000 nm region, and preferably in the 400-800 nm region.Type: GrantFiled: February 4, 2000Date of Patent: October 4, 2005Inventor: Johannes Willem Hofstraat
-
Patent number: 6949508Abstract: Foreign proteins are placed into the blood of an animal so that they can be recovered at a later time and used for identification. Proteins are administered to the animal from a water bath via the animal's gills (where appropriate), gut and, through the skin. The foreign protein is detectable in small amounts using immune assays which magnify the available signals or tags in an assay.Type: GrantFiled: March 31, 2003Date of Patent: September 27, 2005Assignee: The United States of America as represented by the Secretary of the NavyInventors: William F. Krise, John L. Sternick
-
Patent number: 6936475Abstract: A modified bioluminescent system comprising a fluorescent molecule covalently linked with a photoprotein, wherein said link between the two proteins has the function to stabilize the modified bioluminescent system and allowing the transfer of the energy by Chemiluminescence Resonance Energy Transfer (CRET).Type: GrantFiled: December 2, 2002Date of Patent: August 30, 2005Assignees: Institut Pasteur, Centre National de la Recherche ScientifiqueInventors: Valérie Baubet, Hervé Le Mouellic, Philippe Brulet
-
Patent number: 6923951Abstract: Methods and compositions for detecting and localizing light originating from a mammal are disclosed. Also disclosed are methods for targeting light emission to selected regions, as well as for tracking entities within the mammal. In addition, animal models for disease states are disclosed, as are methods for localizing and tracking the progression of disease or a pathogen within the animal, and for screening putative therapeutic compounds effective to inhibit the disease or pathogen.Type: GrantFiled: December 16, 2002Date of Patent: August 2, 2005Assignee: Board of Trustees of the Leland Stanford UniversityInventors: Pamela R. Contag, Christopher H. Contag, David A. Benaron
-
Patent number: 6916462Abstract: Methods and compositions for detecting and localizing light originating from a mammal are disclosed. Also disclosed are methods for targeting light emission to selected regions, as well as for tracking entities within the mammal. In addition, animal models for disease states are disclosed, as are methods for localizing and tracking the progression of disease or a pathogen within the animal, and for screening putative therapeutic compounds effective to inhibit the disease or pathogen.Type: GrantFiled: December 16, 2002Date of Patent: July 12, 2005Assignee: Board of Trustees of the Leland Stanford Junior UniversityInventors: Pamela R. Contag, Christopher H. Contag, David A. Benaron
-
Patent number: 6911305Abstract: The invention provides chemiluminescent assays that incorporate a film including at least one chemiluminescent precursor immobilized therewith which produces a triggerable chemiluminescent compound, the film being free of compounds which generate singlet oxygen and being adapted for use with a sensitizer-labeled agent or agent probative of the analyte.Type: GrantFiled: March 30, 2004Date of Patent: June 28, 2005Assignee: emp Biotech GmbHInventors: Derek W. K. Levison, Uwe Moller, Stuart Levison
-
Patent number: 6908746Abstract: A rapid method for detecting spoilage of a food sample, particularly a fish sample, by detecting and enumerating sulfide-producing bacteria (SPB). A growth medium containing iron and sulfur is combined with the food sample forming an incubation mixture which is incubated for a period of time. In one embodiment, a plurality of fluorescence measurements are taken during an incubation period of about 3 hours to 17 hours at 30° C. SPB are determined to be present in the sample if the fluorescence measurement initially increases and then decreases to form a fluorescence maximum (peak). The time to detection of the fluorescence peak can be used with a correlation schedule to enumerate the SPB in the food sample. In another embodiment, a visual test can also be used to identify color changes in the incubation mixture to provide a semi-quantitative enumeration of SPB effective after about 3 hours to 17 hours of incubation.Type: GrantFiled: October 10, 2003Date of Patent: June 21, 2005Assignee: Colifast ASInventors: Grete Lorentzen, Olaug Taran Skjerdal, James D. Berg
-
Patent number: 6908737Abstract: A method for multiplexed detection and quantification of analytes by reacting them with probe molecules attached to specific and identifiable carriers. These carriers can be of different size, shape, color, and composition. Different probe molecules are attached to different types of carriers prior to analysis. After the reaction takes place, the carriers can be automatically analyzed. This invention obviates cumbersome instruments used for the deposition of probe molecules in geometrically defined arrays. In the present invention, the analytes are identified by their association with the defined carrier, and not (or not only) by their position. Moreover, the use of carriers provides a more homogenous and reproducible representation for probe molecules and reaction products than two-dimensional imprinted arrays or DNA chips.Type: GrantFiled: April 9, 2002Date of Patent: June 21, 2005Assignee: Vitra Bioscience, Inc.Inventors: Ilya Ravkin, Simon Goldbard, William C. Hyun, Michael A. Zarowitz
-
Patent number: 6908605Abstract: Methods and compositions for detecting and localizing light originating from a mammal are disclosed. Also disclosed are methods for targeting light emission to selected regions, as well as for tracking entities within the mammal. In addition, animal models for disease states are disclosed, as are methods for localizing and tracking the progression of disease or a pathogen within the animal, and for screening putative therapeutic compounds effective to inhibit the disease or pathogen.Type: GrantFiled: December 16, 2002Date of Patent: June 21, 2005Assignee: Board of Trustees of the Leland Stanford Junior UniversityInventors: Pamela R. Contag, Christopher H. Contag, David A. Benaron
-
Patent number: 6897036Abstract: Methods of producing fluorescence from fluorogenic substrates reactive with a peroxidase enzyme are disclosed. Use of the methods in assays for peroxidase enzymes, peroxidase-labeled analytes are provided. Fluorogenic compounds, compositions and kits for reaction with peroxidase enzymes are described. Two modes of producing fluorescent compounds are described.Type: GrantFiled: June 6, 2002Date of Patent: May 24, 2005Assignee: Lumigen, Inc.Inventors: Hashem Akhavan-Tafti, Renuka de Silva, Mark Sandison, Richard Handley
-
Patent number: 6890515Abstract: Methods an compositions for detecting and localizing light originating from a mammal are disclosed. Also disclosed are methods for targeting light emission to selected regions, as well as for tracking entities within the mammal. In addition, animal models for disease state are disclosed, as are methods for localizing and tracking the progression of disease or a pathogen within the animal, and for screening putative therapeutic compounds effective to inhibit the disease or pathogen.Type: GrantFiled: December 16, 2002Date of Patent: May 10, 2005Assignee: Board of Trustees of the Leland Stanford Junior UniversityInventors: Pamela R. Contag, Christopher H. Contag, David A. Benaron
-
Patent number: 6872828Abstract: Novel compounds comprising a C—C double bond substituted at one carbon with two sulfur atom-containing groups are disclosed. The compounds are useful in methods and compositions for generating chemiluminescence rapidly by reaction with a peroxidase enzyme and a peroxide. The chemiluminescence thus produced can be used as a detectable signal in assays for peroxidase enzymes or peroxide-producing enzymes and in assays employing enzyme-labeled specific binding pairs.Type: GrantFiled: December 20, 2001Date of Patent: March 29, 2005Assignee: Lumigen, Inc.Inventors: Hashem Akhavan-Tafti, Renuka de Silva, Wenhua Xie
-
Patent number: 6867014Abstract: The present invention provides an enzymatic cycling assay for assessing the amount of homocysteine and/or cystathionine in a solution such as blood, blood derivatives, or urine. The assay comprises the steps of contacting the solution containing homocysteine and/or cystathionine to form a reaction mixture, with CBS, or a derivative thereof, L-serine, and CBL, or a derivative thereof, for a time period sufficient to catalyze the cyclical conversion of homocysteine form to cystathionine and the reconversion of cystathionine to homocysteine with the production of pyruvate and ammonia; determining the amount of homocysteine and/or ammonia present in the reaction mixture; and determining the amount of homocysteine and/or cystathionine present in the solution based on the amount of pyruvate and/or ammonia formed. Expression vectors and isolation procedures for CBS, or derivatives thereof, and CBL, or derivatives thereof, are also provided as well as test kits for carrying out the assay.Type: GrantFiled: August 28, 2003Date of Patent: March 15, 2005Inventors: Glenn Kawasaki, Heather Kay Webb, Jeffrey Owens, Raymond Liedtke, Doreen Forest, Mark Legaz, Sobomabo Lawson
-
Patent number: 6858733Abstract: Novel compounds comprising a C—C double bond substituted at one carbon with two sulfur atom-containing groups are disclosed. The compounds are useful in methods and compositions for generating chemiluminescence rapidly by reaction with a peroxidase enzyme and a peroxide. The chemiluminescence thus produced can be used as a detectable signal in assays for peroxidase enzymes or peroxide-producing enzymes and in assays employing enzyme-labeled specific binding pairs.Type: GrantFiled: July 25, 2002Date of Patent: February 22, 2005Assignee: Lumigen, Inc.Inventors: Hashem Akhavan-Tafti, Renuka de Silva, Wenhua Xie
-
Patent number: 6849396Abstract: The present invention provides methods and apparatus for purifying metabolites of interest and conducting metabolic analyses. The methods generally involve determining metabolic flux values for a plurality of target analytes by monitoring the relative isotope abundance of a stable isotope in a substrate labeled with the stable isotope and/or one or more target metabolites formed through metabolism of the labeled substrate. Certain methods utilize multiple electrophoretic methods to separate the target analytes from other components within the sample being analyzed. The methods can be used in a variety of applications including screens to identify metabolites that are correlated with certain diseases and diagnostic screens for identifying individuals having, or susceptible to, a disease.Type: GrantFiled: October 17, 2003Date of Patent: February 1, 2005Assignee: Target Discovery, Inc.Inventor: Luke V. Schneider
-
Patent number: 6846645Abstract: A mutiplexed enzyme assay method and substrate set for performing the method are disclosed. The method includes performing a plurality of enzyme reactions in the presence of a plurality of enzymes substrates, under conditions effective to convert an enzyme substrate to a corresponding product, where the product of each substrate and the substrate have different separation characteristics from each other and from the other substrates and their corresponding products. After performing the reactions, which may be carried out in separate or combined reactions, the substrates and products in said reactions are separated in a single separation medium. For each separated product and substrate, a separation characteristic effective to identify that product and substrate and a signal related to the amount of the product and substrate is detected. From this, one can determine the amount of substrate converted to the corresponding product in each of the reactions.Type: GrantFiled: July 2, 2003Date of Patent: January 25, 2005Assignee: Aclara Biosciences, Inc.Inventors: Qifeng Xue, Ian Gibbons
-
Patent number: 6828116Abstract: Disclosed is a non-fluorescent cyanine dye that may be used as an acceptor in fluorescence energy transfer assays involving the detection of binding and/or cleavage events in reactions involving biological molecules, and assay methods utilising such dyes.Type: GrantFiled: February 15, 2001Date of Patent: December 7, 2004Assignee: Amersham Biosciences UK LimitedInventors: Alan L. Hamilton, Martyn N. Birch, Malcolm J. Hatcher, Nigel Bosworth, Brian Scott
-
Patent number: 6818413Abstract: The invention relates to novel fluorescence-based assays for protein kinases and phosphatases which can be used in high throughput screening. The methods of the invention utilize a competitive immunoassay to determine the amount of substrate that is phosphorylated or dephosphorylated during the course of a kinase or phosphatase reaction to yield a product, as well as the phosphorylating or dephosphorylating activity of a kinase or phosphatase.Type: GrantFiled: June 20, 2003Date of Patent: November 16, 2004Assignee: Pharmacia and Upjohn CompanyInventors: Dennis E. Epps, Charles K. Marschke
-
Patent number: 6811990Abstract: The present invention provides a set of methods and compositions for homogeneous coupled luminescent assays of cytotoxicity and/or proliferation of cells, as well as for enzymatic activity. In both cases the activities of the enzymes of interest are coupled to production of a high-energy molecule, which serves as a substrate for the production of light by a luciferase, typically in a single reagent mixture, with a useful readout available in 1—5 minutes. Individual cytotoxicity and proliferation signals can be measured from a single sample in 6 minutes or less. The invention also provides a 3-minute, one-step phosphatase assay. The ability to couple the activity of interest to light production in a one-step procedure gives rise to extremely rapid and flexible methods for measurement of cytotoxic effects and enzymatic activities. The assay methods are highly suitable for use in high-throughput screening procedures.Type: GrantFiled: February 8, 2002Date of Patent: November 2, 2004Inventors: Michael J. Corey, Robert J. Kinders
-
Patent number: 6803185Abstract: The invention provides a method for measuring an acyl coenzyme A (acyl CoA) ester or esters in a sample, comprising the steps of: a) forming a reaction mixture comprising the sample to be tested and a derivatizing agent; b) allowing the sample and said derivatizing agent to react, so as to form a fluorescent derivative(s) of any acyl CoA ester(s) present in the sample; and c) determining a level of said fluorescent derivative(s).Type: GrantFiled: February 19, 2002Date of Patent: October 12, 2004Assignee: The University of YorkInventors: Ian Alexander Graham, Tony Robert Larson
-
Patent number: 6800492Abstract: A modified bioluminescent system comprising a fluorescent molecule covalently linked with a photoprotein, wherein said link between the two proteins has the function to stabilize the modified bioluminescent system and allowing the transfer of the energy by Chemiluminescence Resonance Energy Transfer (CRET).Type: GrantFiled: May 24, 2001Date of Patent: October 5, 2004Assignee: Institute PasteurInventors: Valerie Baubet, Hervé LeMouellic, Philippe Brulet
-
Patent number: 6794158Abstract: This invention is directed to a fluorescence polarization assay useful in the detection and evaluation of soluble epoxide hydrolase (sEH) inhibitors. This invention also relates to novel fluorescent probes used in the fluorescence polarization assay, and methods of manufacturing such fluorescent probes. This fluorescent probe of the invention is a compound having the following formula (I): X-spacer-R1-Y (I) wherein X is the radical of compound that binds to the active site of soluble epoxide hydrolase, Y is a fluorescent label, and “spacer” and R1 are as defined herein.Type: GrantFiled: March 28, 2002Date of Patent: September 21, 2004Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.Inventors: Richard Harold Ingraham, Mario G. Cardozo, Christine Anne Grygon, Rachel Rebecca Kroe, John Robert Proudfoot
-
Patent number: RE39047Abstract: A light emitting method of an acridinium ester, comprising reacting said acridinium ester and a superoxide anion, and a method of detecting a substance to be examined, comprising detecting a light emitted by reacting a superoxide anion with an acridinium ester used as a label am described. It is possible to carry out the reaction not under strongly alkaline conditions but around the neutral point and to generate strong luminescence which is stable over a long period of time.Type: GrantFiled: March 8, 2001Date of Patent: March 28, 2006Assignee: Mitsubishi Kagaku Iatron, Inc.Inventors: Masuo Aizawa, Michiko Ikariyama, Eiry Kobatake, Minoru Ogasawara, Mitsunao Tanaka, Yoshihito Ikariyama